|
|
|
| Webinar: Reducing Risks by Outsourcing Your OSD Manufacturing and Packaging | Join Ropack on October 23rd as we explore how outsourcing can facilitate access to advanced equipment, streamline production scaling, and minimize risks related to supply chain disruptions and regulatory challenges. Whether considering outsourcing or currently engaging in outsourcing, we will provide valuable insights to help you make informed decisions that align with your operational and strategic goals. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Facility Maintenance – an all-encompassing descriptor. It starts with taking care of an internal ecosphere – everything from roof to floor. It also includes an exosphere – the real estate the facilities sit on, the business parks where they are located, and the communities they reside within. When you are outsourcing, it makes you a part of it all as well. How much do you know about this area of your CDMO's existence? |
|
|
EMA Issues Draft Guideline On Oligonucleotides Development, Manufacture | By Peter H. Calcott, Ph.D., Calcott Consulting LLC | The EMA recently issued a draft guidance, Guideline on the Development and Manufacture of Oligonucleotides. It includes requirements and considerations related to conjugation, active substance in solution, and more. The consultation period ends Jan. 31, 2025. |
|
|
|
|
The High Potent Market And The Role Of A Specialist CDMO | Article | By Dr Rebecca Coutts, Ph.D., PCI Pharma Services | Safe handling of HPAPIs is complex and the associated regulatory requirements are growing. Discover how leveraging a CDMO can ensure treatments reach patients faster, safely, and cost-effectively. |
|
|
|
|
|
|
Oral Solid Dosage Development And Manufacturing | Pharma Expanse | Our network currently spans across nine manufacturing sites in five countries and can support discovery, preclinical, clinical and commercial programs for New Chemical Entities (NCEs). |
|
|
Commercial Drug Sourcing For Clinical Trials | Catalent | Learn how the right partner can leverage years of experience, market knowledge, industry relationships, and clinical packaging expertise to develop a sourcing strategy tailored to the needs of each study. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|